Nightingale Health Oyj announced Chief R&D Officer Dr. Salla Ruosaari has been appointed to lead the company's product organization, and the company's Chief Product Officer Osma Ahvenlampi will be leaving the company to pursue other career opportunities. In her role, Ruosaari is responsible for developing services based on the company's Health Data Platform and delivering such services to customers using superior digital solutions. With this change, Nightingale's key assets will be even more integrated to rapidly build products and create value for Nightingale's partners and consumer customers. The company's product organization will be further strengthened by the strategic partnership with Reaktor.